Montreal – November 28, 2022 – The U.S. Food and Drug Administration (FDA) approved the first gene therapy for hemophilia B on November 22. Etranacogene...
Each year the CHS honours individuals who have made a significant contribution to improving the quality of life of people with bleeding disorders. The 2023...
HIV Justice News published the following on October 28: “The past two weeks has seen some important HIV Justice advances in three countries – Canada,...
The tainted blood tragedy is incontestably the worst public health disaster that Canada has ever faced. Today, October 27, anniversary of the creation of the...
by Zander Masser, Montreal, QC On a fall day in 1996, my parents called a family meeting. I was 11 years old. My brother was...
The CHS is hiring a National Community Programs Manager. We would greatly appreciate it if you could share this career opportunity with your network. Thank...
The CHS is announcing its Call for Applications for its research programs for the 2023-2024 grant period. The deadline to submit applications for all the...
Montreal, September 7, 2022 – “The Canadian Hemophilia Society (CHS) strongly supports Canadian Blood Services’ plans to work with a leading company in the plasma...
The CHS is deeply saddened to hear of the passing on August 20, 2022, of a former Nova Scotia Chapter President, Janet Conners, at age...
by Wendy Quinn, President of the Canadian Hemophilia Society This summer I had the great privilege of finally attending the infamous Camp Blast – the...
Montreal, August 15, 2022 – On July 15, Héma-Québec announced the results of the recombinant factor IX tender for the period from October 1, 2022...
In an effort to bring young volunteers into the CHS, and in recognition that a sound education is of utmost importance particularly for those who...
The highly popular and useful FactorFirst card has been revised and the new version is now available for orders! Thank you to a great team...
Companies will likely make submissions to Health Canada for approval of gene therapies for hemophilia A and B in the next 6-12 months. To best...